Co-infection and Cancer (R21 Clinical Trial Not Allowed) (344904)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The grant aims to support mechanistic and epidemiologic studies that investigate the roles of co-infection in cancer development. It focuses on enhancing understanding of how co-infections, involving two or more infectious agents including viruses, bacteria, parasites, and other microorganisms, contribute to carcinogenesis. This may help inform future prevention and treatment strategies for infection-related cancers. Special preference is given to research on co-infections with known oncogenic agents (excluding HIV) and studies that propose new avenues for prevention and treatment.

Eligibility

Organization's Location
ipsum commodo
Program Location
sit
Organization Type
up to 275k

Submission

Schedule
Step 1: ad minim esse
Application deadline
Dec 23, 2024
Step 2: voluptate eu (amet dolor)
Sign up to view more grants
Already have an account?Log in